Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
Top Cited Papers
- 20 January 2009
- journal article
- review article
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 86 (3), 151-164
- https://doi.org/10.1016/j.yexmp.2009.01.004
Abstract
No abstract availableKeywords
This publication has 165 references indexed in Scilit:
- T40214/PEI complex: A potent therapeutics for prostate cancer that targets STAT3 signalingThe Prostate, 2008
- Cell-surface nucleolin is a signal transducing P-selectin binding protein for human colon carcinoma cellsExperimental Cell Research, 2008
- In vitro selection and characterization of RNA aptamers binding thyroxine hormoneBiochemical Journal, 2007
- Cell Cycle-controlled Interaction of Nucleolin with the Retinoblastoma Protein and Cancerous Cell TransformationPublished by Elsevier ,2006
- An Acidic Peptide Sequence of Nucleolin-Related Protein Can Mediate the Attachment of Calcium Oxalate to Renal Tubule CellsJournal of the American Society of Nephrology, 2004
- Telomere‐based DNA damage responses: a new approach to melanomaThe FASEB Journal, 2004
- Induction of a p95/Nbs1‐mediated S phase checkpoint by telomere 3′ overhang specific DNAThe FASEB Journal, 2002
- Nucleolin as Activator of Human Papillomavirus Type 18 Oncogene Transcription in Cervical CancerThe Journal of Experimental Medicine, 2002
- c-myc Suppression in Burkitt's Lymphoma CellsBiochemical and Biophysical Research Communications, 2002
- Selective Activation of Antitumor Activity of Macrophages by the Delivery of Muramyl Dipeptide Using a Novel Polynucleotide-Based Carrier Recognized by Scavenger ReceptorsBiochemical and Biophysical Research Communications, 2000